已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020

入射(几何) 食管癌 医学 人口学 死亡率 癌症 腺癌 内科学 光学 物理 社会学
作者
Eileen Morgan,Isabelle Soerjomataram,Harriet Rumgay,Helen G. Coleman,Aaron P. Thrift,Jérôme Vignat,Mathieu Laversanne,Jacques Ferlay,Melina Arnold
出处
期刊:Gastroenterology [Elsevier]
卷期号:163 (3): 649-658.e2 被引量:427
标识
DOI:10.1053/j.gastro.2022.05.054
摘要

Background & AimsThe aim of this study was to provide an overview of the burden of esophageal cancer in 185 countries in 2020 and projections for the year 2040.MethodsEstimates of esophageal cancer cases and deaths were extracted from the GLOBOCAN database for 2020. Age-standardized incidence and mortality rates were calculated overall, by sex, histologic subtype (adenocarcinoma [AC] and squamous cell carcinoma [SCC]), country, and level of human development for 185 countries. The predicted burden of incidence and mortality in 2040 was calculated based on global demographic projections.ResultsGlobally, there were an estimated 604,100 new cases of, and 544,100 deaths from, esophageal cancer in 2020, corresponding to age-standardized incidence and mortality rates of 6.3 and 5.6 per 100,000, respectively. Most cases were SCCs (85% [512,500 cases]) and 14% (85,700 cases) were ACs. Incidence and mortality rates were 2- to 3-fold higher in male (9.3 and 8.2, respectively) compared with female (3.6 and 3.2, respectively) individuals. Global variations in incidence and mortality were observed across countries and world regions; the highest rates occurred in Eastern Asia and Southern and Eastern Africa and the lowest occurred in Western Africa and Central America regions. If rates remain stable, 957,000 new cases (141,300 AC cases and 806,000 SCC cases) and 880,000 deaths from esophageal cancer are expected in 2040.ConclusionsThese updated estimates of the global burden of esophageal cancer represent an important baseline for setting priorities in policy making and developing and accelerating cancer control initiatives to reduce the current and projected burden. Although primary prevention remains key, screening and early detection represent important components of esophageal cancer control in high-risk populations. The aim of this study was to provide an overview of the burden of esophageal cancer in 185 countries in 2020 and projections for the year 2040. Estimates of esophageal cancer cases and deaths were extracted from the GLOBOCAN database for 2020. Age-standardized incidence and mortality rates were calculated overall, by sex, histologic subtype (adenocarcinoma [AC] and squamous cell carcinoma [SCC]), country, and level of human development for 185 countries. The predicted burden of incidence and mortality in 2040 was calculated based on global demographic projections. Globally, there were an estimated 604,100 new cases of, and 544,100 deaths from, esophageal cancer in 2020, corresponding to age-standardized incidence and mortality rates of 6.3 and 5.6 per 100,000, respectively. Most cases were SCCs (85% [512,500 cases]) and 14% (85,700 cases) were ACs. Incidence and mortality rates were 2- to 3-fold higher in male (9.3 and 8.2, respectively) compared with female (3.6 and 3.2, respectively) individuals. Global variations in incidence and mortality were observed across countries and world regions; the highest rates occurred in Eastern Asia and Southern and Eastern Africa and the lowest occurred in Western Africa and Central America regions. If rates remain stable, 957,000 new cases (141,300 AC cases and 806,000 SCC cases) and 880,000 deaths from esophageal cancer are expected in 2040. These updated estimates of the global burden of esophageal cancer represent an important baseline for setting priorities in policy making and developing and accelerating cancer control initiatives to reduce the current and projected burden. Although primary prevention remains key, screening and early detection represent important components of esophageal cancer control in high-risk populations.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
冷酷愚志完成签到,获得积分10
2秒前
zhangyafei发布了新的文献求助10
2秒前
peanuttt完成签到,获得积分10
4秒前
都是发布了新的文献求助10
5秒前
5秒前
01完成签到,获得积分10
6秒前
peanuttt发布了新的文献求助30
7秒前
简单的思菱完成签到 ,获得积分10
7秒前
Freya发布了新的文献求助10
8秒前
活泼红牛发布了新的文献求助10
8秒前
语音助手完成签到 ,获得积分10
9秒前
商毛毛完成签到,获得积分10
12秒前
乐乐应助小小时光采纳,获得10
13秒前
17秒前
17秒前
乐观蚂蚁完成签到 ,获得积分10
18秒前
小二郎应助可靠的念柏采纳,获得10
18秒前
19秒前
19秒前
20秒前
科研通AI2S应助cyy采纳,获得10
22秒前
houl发布了新的文献求助10
23秒前
24秒前
24秒前
沈惠映完成签到 ,获得积分10
26秒前
up完成签到,获得积分20
27秒前
爆米花应助Freya采纳,获得10
28秒前
今后应助风中的丝袜采纳,获得10
29秒前
大方易梦完成签到 ,获得积分10
30秒前
Henry给Muller的求助进行了留言
31秒前
gugu完成签到 ,获得积分10
31秒前
自然钢笔完成签到 ,获得积分10
36秒前
牛牛发布了新的文献求助10
37秒前
40秒前
NexusExplorer应助liweiDr采纳,获得10
41秒前
43秒前
Landau完成签到,获得积分10
47秒前
天天快乐应助nater4ver采纳,获得10
49秒前
50秒前
高分求助中
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Handbook of Qualitative Cross-Cultural Research Methods 600
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3139294
求助须知:如何正确求助?哪些是违规求助? 2790209
关于积分的说明 7794379
捐赠科研通 2446597
什么是DOI,文献DOI怎么找? 1301309
科研通“疑难数据库(出版商)”最低求助积分说明 626124
版权声明 601109